Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-α blocker therapy

Rheumatology

Volumn 49, Issue 2, 2010, Pages 264-270

  Chen, Chun Hsiung ^a,b,c   Liao, Hsien Tzung ^a,b,c   Chen, Hung An ^e   Liu, Chin Hsiu ^c   Liang, Toong Hua ^d   Wang, Chin Tien ^a,b   Tsai, Chang Youh ^a,b   Chou, Chung Tei ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Ankylosing spondylitis; Disease activity; HLA G; Mononuclear cells; Spinal mobility; TNF blocker

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; HLA G ANTIGEN;

ADULT; ANKYLOSING SPONDYLITIS; ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE PREDISPOSITION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL MOBILITY; PRIORITY JOURNAL; SPINE MOBILITY; UPREGULATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950396801     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep360     Document Type: Article

References (29)

1. Zochling J, Brandt J, Braun J. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology 2005;44:1483-91.
2. Favier B, LeMaoult J, Rouas-Freiss N, Moreau P, Menier C, Carosella ED. Research on HLA-G: an update. Tissue Antigens 2007;69:207-11.
3. Bainbridge D, Ellis S, Le Bouteiller P, Sargent I. HLA-G remains a mystery. Trends Immunol 2001;22:548-52.
4. Fuzzi B, Rizzo R, Criscuoli L et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002;32:311-5.
5. Le Bouteiller P, Mallet V. HLA-G and pregnancy. Rev Reprod 1997;2:7-13.
6. Rouas-Freiss N, Gonçalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997;94:11520-5.
7. Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000;355:2138.
8. Adrián Cabestré F, Moreau P, Riteau B et al. HLA-G expression in human melanoma cells: protection from NK cytolysis. J Reprod Immunol 1999;43:183-93.
9. Wagner SN, Rebmann V, Willers CP, Grosse-Wilde H, Goos M. Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma. Lancet 2000;356:220-1.
10. Verbruggen LA, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H. Soluble HLA-G in rheumatoid arthritis. Hum Immunol 2006;67:561-7.
11. Borghi A, Fogli E, Stignani M et al. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease. Arch Dermatol Res 2008;300:551-9.
12. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
13. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
14. Calin A, Garrett S, Whitelock H et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
15. Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 1996;35:66-71.
16. Braun J, Pham T, Sieper J et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003;62:817-24.
17. Rebmann V, Busemann A, Lindemann M, Grosse-Wilde H. Detection of HLA-G5 secreting cells. Hum Immunol 2003;64:1017-24.
18. Rizzo R, Mapp CE, Melchiorri L et al. Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma. J Allergy Clin Immunol 2005;115:508-13.
19. Rizzo R, Melchiorri L, Simone L et al. Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease: a noninvasive diagnostic tool? Inflamm Bowel Dis 2008;14:100-5.
20. Kennedy LG, Jenkinson TR, Mallorie PA, Whitelock HC, Garrett SL, Calin A. Ankylosing spondylitis: the correlation between a new metrology score and radiology. Br J Rheumatol 1995;34:767-70.
21. Haywood KL, Garratt AM, Jordan K, Dziedzic K, Dawes PT. Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology 2004;43:750-7.
22. Cunnane G, Bresnihan B, FitzGerald O. Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis. Arthritis Rheum 1998;41:180-2.
23. Riteau B, Menier C, Khalil-Daher I et al. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999;43:203-11.
24. Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4({thorn}) T-lymphocytes. J Reprod Immunol 2000;48:17-26.
25. Fournel S, Aguerre-Girr M, Huc X et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000;164:6100-4.
26. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001;166:5018-26.
27. Yang Y, Chu W, Geraghty DE, Hunt JS. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J Immunol 1996;156:4224-31.
28. Moreau P, Adrian-Cabestre F, Menier C et al. IL-10 selectively induces HLA-G expression in human trophoblast and monocytes. Int Immunol 1999;5:803-11.
29. Claudepierre P, Rymer JC, Chevalier X. IL-10 plasma levels correlate with disease activity in spondyloarthropathy. J Rheumatol 1997;24:1659-61.